RBx,
Please clarify this "statement" you made:
"A search will show that the Cantrixil Phase 1 abstract has been accepted as a poster presentation at ESMO in September, but unfortunately it looks like the data was not good enough to warrant an oral presentation."
Who is in the know on the contents of the presentation? Trial investigator? Kazia Management? I'm quite sure Kazia has to disclose any material information as soon as they have it.
Are you just making things up or is your statement factual.
- Forums
- ASX - By Stock
- KZA
- Value of Cantrixil
Value of Cantrixil, page-4
-
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KZA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online